Myovant Sciences Ltd.
MYOVNYSEHealthcare
$26.98
$-0.01(-0.04%)
Market Cap$2.6B
P/E Ratio—
52W High$27.06
52W Low$7.67
Myovant Sciences Ltd. (MYOV) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MYOV · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-03 | 2021-03 | 2020-03 | 2019-03 | 2018-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.23B | $0.06B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.05B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.18B | $0.06B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | 77.68% | 96.69% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.11B | $0.14B | $0.19B | $0.22B | $0.12B |
| G&A Expenses | $0.00B | $0.00B | $0.08B | $0.04B | $0.02B |
| Total Operating Expenses | $0.37B | $0.32B | $0.27B | $0.26B | $0.14B |
| Operating Income | ($0.19B) | ($0.26B) | ($0.27B) | ($0.26B) | ($0.14B) |
| Operating Margin %(computed) | -81.11% | -439.64% | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | ($0.20B) | ($0.25B) | ($0.29B) | ($0.27B) | ($0.14B) |
| Income Tax Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.21B) | ($0.26B) | ($0.29B) | ($0.27B) | ($0.14B) |
| Net Margin %(computed) | -89.18% | -430.12% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.22 | $-2.83 | $-3.37 | $-4.09 | $-2.41 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.09B | 0.07B | 0.06B |
| EBITDA | ($0.18B) | ($0.24B) | ($0.27B) | ($0.26B) | ($0.14B) |
| EBITDA Margin %(computed) | -79.62% | -407.84% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Myovant Sciences Ltd. data
About Myovant Sciences Ltd. (MYOV) Income Statement
Myovant Sciences Ltd. (MYOV) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, MYOV reported revenue of $0.23B, gross profit of $0.18B (gross margin 77.68%), and net income of ($0.21B) — a net profit margin of -89.18%.
Frequently asked questions
MYOV · 4 questionsMyovant Sciences Ltd. (MYOV) reported revenue of $0.23B for 2022, up 289.4% year-over-year.
MYOV revenueMYOV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08